Enyedy Mark J 4

Accession 0001415889-23-011881

CIK 0000855654other

View on SEC.gov Company Profile

Filed

Aug 3, 8:00 PM ET

Accepted

Aug 4, 7:32 PM ET

Size

35.0 KB

Accession

0001415889-23-011881

Insider Transaction Report

Form 4

Period: 2023-08-02

ImmunoGen, Inc.IMGN

Enyedy Mark J

DirectorChief Executive Officer

Transactions

Exercise/Conversion
Common Stock
2023-08-02$4.55/sh+995,157$4,527,964→ 1,436,606 total
Sale
Common Stock
2023-08-02$17.45/sh−986,521$17,214,791→ 450,085 total
Exercise/Conversion
Common Stock
2023-08-04$5.25/sh+782,240$4,106,760→ 1,223,689 total
Sale
Common Stock
2023-08-04$16.96/sh−992,397$16,831,053→ 553,270 total
Sale
Common Stock
2023-08-03$16.61/sh−1,020,000$16,942,200→ 441,449 total
Sale
Common Stock
2023-08-02$18.15/sh−8,636$156,743→ 441,449 total
Exercise/Conversion
Common Stock
2023-08-03$5.25/sh+2,760$14,490→ 444,209 total
Exercise/Conversion
Common Stock
2023-08-03$4.55/sh+1,017,240$4,628,442→ 1,461,449 total
Exercise/Conversion
Common Stock
2023-08-04$4.55/sh+21,978$100,000→ 1,245,667 total
Exercise/Conversion
Common Stock
2023-08-04$5.65/sh+300,000$1,695,000→ 1,545,667 total
Exercise/Conversion
Stock Option (Right to Buy)
2023-08-02−995,157→ 382,968 total
Exercise: $4.55From: 2022-11-14Exp: 2030-02-07→ Common Stock (995,157 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2023-08-03−831,147→ 218,853 total
Exercise: $4.55From: 2021-02-07Exp: 2030-02-07→ Common Stock (831,147 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2023-08-04−300,000→ 0 total
Exercise: $5.65From: 2017-05-16Exp: 2026-05-16→ Common Stock (300,000 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2023-08-04−21,978→ 196,875 total
Exercise: $4.55From: 2021-02-07Exp: 2030-02-07→ Common Stock (21,978 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2023-08-03−2,760→ 782,240 total
Exercise: $5.25From: 2020-01-31Exp: 2029-01-31→ Common Stock (2,760 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2023-08-03−186,093→ 196,875 total
Exercise: $4.55From: 2022-11-14Exp: 2030-02-07→ Common Stock (186,093 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2023-08-04−782,240→ 0 total
Exercise: $5.25From: 2020-01-31Exp: 2029-01-31→ Common Stock (782,240 underlying)

Footnotes (7)

[F1]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.14 to $18.11, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within these ranges.
[F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.50 to $17.01, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within these ranges.
[F3]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.65 to $17.17, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within these ranges.
[F4]The options vested in installments upon the satisfaction of certain performance criteria.
[F5]Exercisable in three equal installments over three years starting on the first year anniversary of the grant.
[F6]Exercisable as to 25% on the first year anniversary of the grant and 6.25% quarterly for the subsequent three years.
[F7]Exercisable in four equal installments over four years starting on the first year anniversary of the grant.

Documents

1 file

4
form4-08042023_110845.xmlPrimary

Issuer

ImmunoGen, Inc.

CIK 0000855654

→

Entity typeother

Related Parties

filerCIK 0001586965

Filing Metadata

Form type: 4
Filed: Aug 3, 8:00 PM ET
Accepted: Aug 4, 7:32 PM ET
Size: 35.0 KB

View on SEC.gov